HONOLULU – Could gut microbiota be a better predictor than clinical factors of a patient’s response to treatment for Clostridium difficile infection?
In a study of 88 patients with C....
HONOLULU – Ustekinumab, a monoclonal antibody targeted against interleukins 12 and 23 (IL-12 and IL-23), met its primary endpoint for control of Crohn’s disease in a multinational phase III trial...
HONOLULU – A survey of almost 500 physicians found that primary care physicians (PCPs) are far more concerned about the reported adverse effects of proton pump inhibitors (PPIs) than are...
SAN DIEGO – Fecal microbiota transplantation (FMT) is now first-line therapy for Clostridium difficile infection (CDI) in much of Scandinavia. At an annual conference on infectious diseases,...
CHICAGO – Diverting loop ileostomy may be a better option than urgent colectomy as the first surgical step for medically refractory severe ulcerative colitis and Crohn’s disease.
Investigators from...
The Food and Drug Administration has issued a safety alert warning of possible serious liver injury as a result of the hepatitis C drugs Viekira Pak and Technivie, the agency announced Oct. 22.
A...
HONOLULU – Fecal transplant was shown to be effective in the treatment of recurrent or refractory episodes of Clostridium difficile infection in a double-blind trial for the first time, and a...
HONOLULU – Obese patients who develop an upper GI bleed receive more treatment, are more likely to develop hemorrhagic shock, and are more likely to require admission to an intensive care unit than...
SAN DIEGO – Researchers found “no compelling evidence” that carbapenem-resistant enterobacteriaceae were transmitted to Veterans Affairs patients during more than 55,000 endoscopic retrograde...
SAN DIEGO – Despite better therapies, deaths from hepatitis C virus (HCV) infection continue to rise, indicating poor penetrance of medications and care to patients who need them, Dr. Scott Holmberg...
